Muscle and Combo Therapies Likely Next Focus for SMA & DeAnn Runge's 3 Year Journey With Spinraza

SMA News Today’s multimedia associate, Price Wooldridge, discusses the likely next focus of muscle and combo therapies for Spinal Muscular Atrophy (SMA).

DeAnn Runge shares her thoughts on her 3 year journey with Spinraza.

Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/